Immunologic Factors: all 3,292 studies that test it
Page 33 of 33. Open to participants first (386), then studies with results posted, then the rest; newest registration first within each.
- Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's LymphomaCompletedNCT00005601Phase 2
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's LymphomaCompletedNCT00005589Phase 3
- Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With NeuroblastomaCompletedNCT00005576Phase 1
- S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's LymphomaCompletedNCT00005089Phase 2
- Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV CancerCompletedNCT00005023Phase 1
- Tocladesine in Treating Patients With Recurrent or Refractory Multiple MyelomaCompletedNCT00004902Phase 2
- Rituximab in Treating Patients With Waldenstrom's MacroglobulinemiaCompletedNCT00004889Phase 2
- Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre SyndromeTerminatedNCT00004833Not applicable
- Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis CCompletedNCT00004804Phase 3
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating PolyneuropathyCompletedNCT00004772Phase 3
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple SclerosisCompletedNCT00004744Phase 3
- Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia GravisTerminatedNCT00004682Not applicable
- Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell MyocarditisCompletedNCT00004482Phase 2
- Intravenous Pertussis Immune Globulin in Patients With Severe Childhood Pertussis InfectionCompletedNCT00004422Phase 3
- Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic NeuropathyTerminatedNCT00004407Not applicable
- Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating NeuropathyCompletedNCT00004286Phase 3
- Interleukin-12 Plus Rituximab in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00004260Phase 1
- Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal CancerCompletedNCT00004256Phase 2
- Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic SyndromeCompletedNCT00004208Phase 3
- Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Stage III or Stage IV Non-Hodgkin's LymphomaCompletedNCT00004198Phase 2
- Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's LymphomaCompletedNCT00004197Phase 2
- Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node MetastasisCompletedNCT00004196Phase 3
- Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV MelanomaCompletedNCT00004184Phase 1/2
- Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's LymphomaCompletedNCT00004179Phase 3
- Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's LymphomaCompletedNCT00004162Phase 1
- Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00004145Phase 2
- Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's LymphomaCompletedNCT00004112Phase 3
- Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After ChemotherapyWithdrawnNCT00004040Phase 2
- Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV LymphomaWithdrawnNCT00004039Phase 2
- Vaccine Therapy in Treating Patients With Metastatic Prostate CancerCompletedNCT00004029Phase 1
- Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell TransplantationCompletedNCT00003963Phase 2
- Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic SyndromeCompletedNCT00003961Phase 2
- Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's LymphomaStatus unknownNCT00003924Phase 3
- Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant MelanomaCompletedNCT00003897Phase 1
- Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's DiseaseCompletedNCT00003849Phase 2
- Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine TherapyCompletedNCT00003757Phase 2
- Monoclonal Antibody Therapy in Treating Patients With Lymphoproliferative Disorder Associated With Immunosuppression TherapyCompletedNCT00003716Phase 2
- Rituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's LymphomaWithdrawnNCT00003663Phase 2
- Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell CancersCompletedNCT00003658Phase 2
- Rituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's LymphomaWithdrawnNCT00003605Phase 2
- Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's LymphomaCompletedNCT00003595Phase 3
- Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaTerminatedNCT00003561Phase 2
- Rituximab in Treating Patients With Multiple MyelomaCompletedNCT00003554Phase 2
- Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the GroinCompletedNCT00003444Phase 3
- Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00003397Phase 2
- Rituximab Plus Interleukin-2 in Treating Patients With LymphomaCompletedNCT00003356Phase 1/2
- Liposomal Amphotericin B With or Without Sargramostim in Treating Patients With Invasive Fungal InfectionCompletedNCT00003315Phase 3
- Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell LymphomaCompletedNCT00003280Phase 3
- Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic LeukemiaCompletedNCT00003248Phase 2
- Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's LymphomaCompletedNCT00003204Phase 3
- Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced TumorsCompletedNCT00003125Phase 2
- Surgery in Treating Children With NeuroblastomaCompletedNCT00003119Phase 3
- Combination Chemotherapy in Treating Children With NeuroblastomaCompletedNCT00003093Phase 3
- Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant MeningiomasCompletedNCT00002965Phase 2
- Topotecan Plus Sargramostim in Treating Patients With Advanced CancerCompletedNCT00002950Phase 1/2
- Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent MelanomaCompletedNCT00002892Phase 3
- S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic AmyloidosisCompletedNCT00002849Phase 2
- Combination Chemotherapy in Treating Patients With LymphomaCompletedNCT00002835Phase 3
- Bone Marrow Transplantation in Treating Patients With LymphomaCompletedNCT00002829Phase 2
- Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell TransplantationCompletedNCT00002787Phase 1
- Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous LeukemiaTerminatedNCT00002778Phase 2
- High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III MelanomaStatus unknownNCT00002763Phase 3
- T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic AnemiaCompletedNCT00002718Phase 2
- Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal CancerWithdrawnNCT00002664Phase 2
- SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ TransplantCompletedNCT00002657Phase 2
- Interferon Alfa in Treating Children With HIV-Related CancerCompletedNCT00002621Phase 2
- Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00002574Phase 2
- Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First RemissionCompletedNCT00002514Phase 3
- Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's LymphomaCompletedNCT00002461Phase 2
- A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic PurpuraCompletedNCT00002250Phase 1
- A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and LeukopeniaCompletedNCT00002009Phase 1
- An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and LeukopeniaCompletedNCT00002008Phase 1
- Combination Therapy of Severe Aplastic AnemiaCompletedNCT00001964Phase 2
- A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic SyndromeCompletedNCT00001839Phase 2
- A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by RituximabCompletedNCT00001805Phase 2
- Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)CompletedNCT00001768Phase 3
- Medical Treatment for Diamond Blackfan AnemiaCompletedNCT00001749Phase 2
- Comparing Therapies for the Treatment of Severe Aplastic AnemiaCompletedNCT00001626Phase 2
- EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated LymphomaCompletedNCT00001563Phase 2
- Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)CompletedNCT00001550Phase 1
- A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' TumorCompletedNCT00001509Phase 2
- Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedNCT00001287Phase 2
- A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related ComplexCompletedNCT00000976Phase 1
- An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant AntigensCompletedNCT00000935Phase 3
- A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related ComplexCompletedNCT00000675Phase 1
- A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 InfectionCompletedNCT00000663Phase 1
- An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV InfectionCompletedNCT00000647Not applicable
- A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their NewbornsCompletedNCT00000642Phase 1
- Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185)CompletedNCT00000590Phase 3
- Transfusion-Transmitted Cytomegalovirus Prevention in NeonatesCompletedNCT00000584Phase 3
- Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune GlobulinCompletedNCT00000580Phase 3
- Intravenous Immunoglobulin Therapy in Optic NeuritisCompletedNCT00000117Phase 3